Search clinical trials for: Capecitabine (Xeloda) Pharmacogenetic Test Reagents

Total 5876 results

Children's Hospital of Philadelphia
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Pharmacologic Impact on Sedation Assessments (PISA)

Pediatric Acute Lung Injury

United States
Corporal Michael J. Crescenz VA Medical Center

Recruiting

PRIME Care (PRecision Medicine In MEntal Health Care) 2.0 (PRIME Care 2)

Psychiatric or Mood Diseases or Conditions

United States
Fudan University

Not yet recruiting

An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer

Rectal Cancer

China
Tabula Rasa HealthCare

Enrolling by invitation

Pharmacist-led Pharmacogenomic Clinical Service Within the Program of All-inclusive Care for the Elderly

Pain | Pain, Acute | Elderly | Opioid Use | Pain, Chronic | Pharmacogenetic Testing

United States
Clínica Origen
ANDROFERT - Clinica de Andrologia e Reproducao Humana; Faculdade de Medicina...

Unknown

Pharmacogenetic Algorithm for Individualized Controlled Ovarian Stimulation

Infertility
Hospital Pharmacy Enterprise, South Eastern Norway
Diakonhjemmet Hospital; University Hospital, Akershus; University of Oslo School...

Completed

Implementation of Pharmacogenetic Testing in Hospital Wards (FAGLIS)

Admitted Multimorbid Patients

Norway
Samsung Medical Center

Withdrawn

Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer

Gastric Cancer

Korea, Republic of
Sun Yat-sen University
Affiliated Cancer Hospital of Shantou University Medical College; Affiliated...

Completed

Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Fudan University

Suspended

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

Gastric Cancer

China
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI)

Gastrointestinal Cancer

United States
Hoffmann-La Roche

Completed

A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal Cancer

Colorectal Cancer

Slovakia
Tianjin Medical University Cancer Institute and...

Unknown

Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients

Stomach Cancer

China
Anna Vlasova
Russian Medical Academy of Continuous Professional Education; Morozov Children...

Completed

Safety Analysis of Antimicrobial Pharmacotherapy in Intensive Care Unit at Pediatric Hospital

Drug Therapy

Russian Federation
University of Michigan

Completed

Pharmacogenomic Testing in Primary Care

Antidepressants Causing Adverse Effects in Therapeutic Use

United States
VA Office of Research and Development

Completed

PRIME Care (PRecision Medicine In MEntal Health Care) (PRIME Care)

Major Depression

United States
National University Hospital, Singapore
The N.1 Institute for Health (N.1)

Recruiting

PRECISE CURATE.AI Pilot Clinical Trial

Solid Tumor

Singapore
Hallym University Medical Center
Sanofi

Completed

Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer

Colorectal Neoplasm

Korea, Republic of
University of Aarhus
Pierre Fabre Laboratories

Completed

Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer (XeNa)

Breast Cancer

Denmark
Hoffmann-La Roche

Completed

A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours

Breast Cancer, Colorectal Cancer

New Zealand, Australia, United Kingdom
VA Office of Research and Development

Completed

Integrating Pharmacogenetics In Clinical Care (I-PICC)

Cardiovascular Disease

United States
Asan Medical Center
Ulsan University Hospital; Seoul National University Bundang Hospital; Gachon... and other collaborators

Recruiting

Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS

Gastric Cancer

Korea, Republic of
Hoffmann-La Roche

Terminated

A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer

Breast Cancer

United States
Hoffmann-La Roche

Completed

A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression

Breast Cancer

France
Cambridge University Hospitals NHS Foundation Trust

Completed

Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United Kingdom
Hoffmann-La Roche

Completed

A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed Gliomas

Glioma

United States
Sun Yat-sen University

Recruiting

A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients (SMART)

Breast Cancer

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Capecitabine in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
Cambridge University Hospitals NHS Foundation Trust

Terminated

Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma

Adenocarcinoma of the Stomach

United Kingdom
Jules Bordet Institute

Completed

Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study

Breast Cancer | Elderly Patients

Belgium
Ain Shams University

Recruiting

Pharmacokinetics of Sofosbuvir/Daclatasvir in HCV-infected Lactating Women

Hepatitis C Virus Infection

Egypt
University of Alabama at Birmingham

Not yet recruiting

Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

Metastatic Breast Cancer

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

A Bioequivalence Study of Capecitabine Tablets

Metastatic Breast Cancer or Metastatic Colorectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

Metastatic Breast Cancer

China
Alaunos Therapeutics

Unknown

Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors

Advanced Solid Tumors

United States
Peking University Cancer Hospital & Institute
Roche Pharma AG

Unknown

Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis

Gastric Cancer

China
James A. Haley Veterans Administration Hospital
Hoffmann-La Roche

Terminated

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

Cancer of Liver

United States
National Cancer Center, Korea
Korean Cancer Study Group

Unknown

Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer (PREPARE)

Adenocarcinoma | Rectal Neoplasms

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.

Gastric Cancer

Taiwan
Sun Yat-sen University

Unknown

Maintenance Treatment With Capecitabine in Colorectal Cancer Patients

Colorectal Neoplasms | Neoplasms Metastasis

China
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Completed

Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma

Brain and Central Nervous System Tumors

United States
ASLAN Pharmaceuticals

Completed

A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours

Advanced or Metastatic Solid Tumors | Advanced or Metastatic Biliary Tract Cancer

Japan
Hoffmann-La Roche

Completed

A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.

Nasopharyngeal Cancer

Morocco
King Faisal Specialist Hospital & Research Center

Completed

A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer

Colon Rectal Cancer Duke Stage Stageval

Saudi Arabia
The First Affiliated Hospital of Zhengzhou University

Recruiting

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

Gastric Cancer

China
Hoffmann-La Roche

Completed

A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

China, United States, South Africa, Russian Federation, Thailand, Bosnia and Herzegovina, Czech Republic, India, Poland
National Cancer Centre, Singapore
Novartis

Terminated

Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer

Gastric Cancer | Colorectal Cancer

Singapore
Hoffmann-La Roche

Completed

A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.

Colorectal Cancer

Russian Federation
Shanghai Jiao Tong University School of Medicine
Ruijin Hospital

Unknown

A Study for Short Preoperative Chemoradiotherapy for Resectable Rectal Carcinoma (IMRT)

Chemoradiotherapy

China
Rambam Health Care Campus
Roche Pharma AG

Unknown

Immunochemotherapy for Metastatic Renal Cell Carcinoma

Adenocarcinoma Clear Cell

Israel
Hebei Medical University

Completed

Preoperative Concurrent Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Esophagogastric Junction (A-C)

Gastroesophageal Junction Adenocarcinoma

China

Search clinical trials for: Capecitabine (Xeloda) Pharmacogenetic Test Reagents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations